Some patients, apparently, need only a small trigger to propel a massive anticancer attack.
In the long term, genetic signatures are also throwing up new leads for anticancer drug design.
Drug resistance and disease progression have been observed all for anticancer drugs that target specific genetic alterations.
Late yesterday, the drug giant recieved approval for Sutent, a new anticancer pill, for both stomach and kidney tumors.
Drug companies including Sanofi, Merck and Pfizer are working on anticancer drugs that block insulin-like growth factor, a related molecule.
That same month pharmaceutical maker Merck KGaA of Germany agreed to co-develop with Chi-Med anticancer drugs derived from natural products.
Over the years numerous trials of anticancer vaccines designed to train the immune system to recognize cancer have shown mostly lackluster results.
For one point about anticancer genes is that several have to go wrong in the same cell before a tumour can grow.
No broad-based anticancer antidotes have emerged from the immune system work yet.
The next stage is to test the nanofactories with DNA that makes proteins which might actually act as drugs anticancer antibodies, for example.
Aspirin, for example, was originally derived from willow bark, and the anticancer drug Taxol comes from the bark of the Pacific yew tree.
The usual treatment is surgery, followed by radiation and anticancer chemicals.
The combination will be used to develop antibody-drug conjugate anticancer therapeutics.
FORBES: Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson
Tom McKillop is quietly turning AstraZeneca into an anticancer powerhouse.
Experiments in his lab indicated the drug had anticancer potential.
Her doctors ordered one more brief round of anticancer drugs.
The drug, Avastin, could hit the market by year-end, joining existing anticancer chemicals and radiation as standard therapy for colon cancer--and it could end up working against other cancers.
That same month pharmaceutical maker Merck (nyse: MRK - news - people ) KGaA of Germany agreed to co-develop with Chi-Med anticancer drugs derived from natural products.
Among their projects: developing a hybrid anticancer compound that combines an antibody with a cancer-targeting small molecule and using algae to quickly grow human antibodies that zero in on herpes.
It has had a relationship with Akorn for three years to market injectable anticancer products and rabies monoclonal antibodies manufactured by Serum, and recently announced it was buying 2 million shares in its American partner.
应用推荐